Learn how long you'll likely receive Keytruda infusions, what factors can affect your treatment length, and what to expect ...
There are concerns about Merck’s ability to successfully navigate the loss of exclusivity period for its blockbuster drug, Keytruda, and potential competition for Keytruda. With a weak fourth ...
Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s Keytruda-challenging ivonescimab in combination with several of its antibody-drug conjugates (ADCs).
March 5 (Reuters) - Merck's (MRK.N), opens new tab injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics (HALO.O ...
AI art generation has been evolving at a wild pace, and Google just threw another big contender into the mix through its Gemini Flash 2.0. You can play with the new image creation tool in Google's ...
Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers targeted for second round of Medicare price talks agreed to participate.
Rohit Sharma led from the front for India in the 2025 Champions Trophy final against New Zealand. (Image Credits: Getty Images) India beat New Zealand by four wickets in yesterday's 2025 Champions ...
Canadian singer Shawn Mendes showed his support for India’s cricket team with a heartfelt gesture ahead of the ICC Tournament final match between India and New Zealand. (Image Credits ...
Historic images of two of the most renowned ships to have plied New Zealand waters in the early 1800s have surfaced thanks to some dogged sleuthing by Whangārei maritime historian Don Armitage.
MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...
The Boys Season 4 was the most divisive entry in the franchise thus far, with critics giving the series a 91% score but general audiences landing at a much lower approval rating of only 54% on the ...
Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results